Research Analysts Set Expectations for GoHealth Q3 Earnings

GoHealth, Inc. (NASDAQ:GOCO) – Equities research analysts at Noble Financial issued their Q3 2026 earnings per share (EPS) estimates for shares of GoHealth in a report issued on Thursday, April 2nd. Noble Financial analyst M. Kupinski anticipates that the company will post earnings of ($1.99) per share for the quarter. Noble Financial has a “Strong-Buy” rating on the stock. The consensus estimate for GoHealth’s current full-year earnings is ($5.50) per share. Noble Financial also issued estimates for GoHealth’s FY2026 earnings at ($8.55) EPS and FY2027 earnings at $1.93 EPS.

Other research analysts also recently issued reports about the company. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of GoHealth in a research report on Monday, December 29th. Freedom Capital downgraded GoHealth from a “strong-buy” rating to a “hold” rating in a research report on Monday. One analyst has rated the stock with a Strong Buy rating, three have issued a Hold rating and one has given a Sell rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and a consensus target price of $5.00.

GoHealth Stock Performance

GOCO opened at $1.16 on Tuesday. The business has a 50 day moving average price of $1.69 and a 200 day moving average price of $2.71. GoHealth has a twelve month low of $1.12 and a twelve month high of $11.36. The firm has a market cap of $33.30 million, a P/E ratio of -0.06 and a beta of 1.61.

GoHealth (NASDAQ:GOCO) last posted its earnings results on Tuesday, March 31st. The company reported ($1.03) earnings per share for the quarter, topping the consensus estimate of ($2.69) by $1.66. GoHealth had a positive return on equity of 8.00% and a negative net margin of 26.95%.The firm had revenue of $12.64 million during the quarter, compared to analyst estimates of $88.62 million.

Institutional Trading of GoHealth

Institutional investors and hedge funds have recently modified their holdings of the company. Goldman Sachs Group Inc. bought a new stake in shares of GoHealth during the fourth quarter valued at approximately $26,000. Benefit Street Partners LLC bought a new stake in shares of GoHealth during the fourth quarter valued at approximately $29,000. Charles Schwab Investment Management Inc. increased its position in shares of GoHealth by 119.3% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 26,448 shares of the company’s stock valued at $57,000 after purchasing an additional 14,388 shares during the period. American Century Companies Inc. bought a new stake in shares of GoHealth during the second quarter valued at approximately $63,000. Finally, Franklin Resources Inc. bought a new stake in shares of GoHealth during the third quarter valued at approximately $66,000. 24.21% of the stock is currently owned by institutional investors.

GoHealth News Roundup

Here are the key news stories impacting GoHealth this week:

• Positive Sentiment: Sidoti raised multiple near-term estimates and trimmed expected losses — the firm boosted Q1–Q3 2026 and several 2027 quarter forecasts and cut its Q3 2026 loss estimate sharply (from ($3.30) to ($1.47)), and also narrowed FY2026 and FY2027 losses, signaling improving margin expectations.
• Positive Sentiment: Noble Financial lifted its FY2027 EPS view materially to a positive $1.93 and retains a “Strong‑Buy” stance, implying at least one analyst expects a recovery into positive earnings by 2027.
• Neutral Sentiment: Sidoti published a full schedule of quarter-by-quarter EPS projections (Q1–Q4 2026/2027 and FY figures), providing updated modeling inputs for investors but not changing consensus direction on current-year losses.
• Negative Sentiment: Noble trimmed its FY2026 view to ($8.55) from ($7.53), increasing near-term expected losses and adding uncertainty to the recovery timeline.
• Negative Sentiment: Freedom Capital downgraded GoHealth from “Strong‑Buy” to “Hold,” a near-term negative for sentiment among retail/small institutional holders. Freedom Capital downgrade
• Negative Sentiment: Fundamentals remain weak: recent quarterly results showed a very large revenue shortfall and continued negative EPS and margins; market cap is small and the company sits near its 52‑week low, making the stock sensitive to analyst sentiment and liquidity.

GoHealth Company Profile

GoHealth, Inc is a technology-driven health insurance marketplace that connects consumers with a wide range of health insurance plans from leading carriers. Through its digital platform, the company facilitates the comparison, selection and enrollment process for individual and family plans, as well as Medicare Advantage and Medicare Supplement products. By leveraging data analytics and customer support services, GoHealth aims to simplify a traditionally complex market and enable more informed decision-making for policyholders.

The company’s online portal integrates real-time quoting tools, educational resources and access to licensed insurance agents, ensuring that users receive personalized guidance throughout the enrollment journey.